Svenska Vaccinfabriken Produktion

Svenska Vaccinfabriken (SVF) is a Swedish biotechnology company dedicated to the development of next-generation DNA-based vaccines and immunotherapies for infectious diseases. Spun out from research at the Karolinska Institutet, the company utilizes its proprietary SVF-DNA platform to design vaccines that elicit potent cellular and humoral immune responses. Its primary focus is on chronic viral infections, with lead programs targeting Hepatitis B and Hepatitis C. SVF aims to overcome the historical limitations of DNA vaccines through optimized gene expression and efficient delivery technologies. The company is headquartered in Stockholm and maintains a strong collaborative network with leading academic and clinical institutions.